FLASCO Fall Session - Florida Society of Clinical Oncology Fall Session

Group of pharmacists -- Image credit: .shock | stock.adobe.com

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

ByNicole Bentivegna, PharmD, BCOP,Gabriela Aponte-Melendez, PharmD,Natalie Kaufman, PharmD,Cooper Bailey, PharmD

December 27th 2024

The program develops patient-centered oncology pharmacists through comprehensive training.

FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer

ByAlana Hippensteele, Lead Editor

November 3rd 2024

Two clinical trials with MRD monitoring may be practice changing: TRACERx and AEGEAN.

Pharmacist Involvement Within ASCO: Standards Development, Certification Programs, and the Potential for Pharmacy CE at Future ASCO Meetings

ByAlana Hippensteele, Lead Editor

November 3rd 2024

ASCO is prioritizing the expansion of pharmacist involvement in its organization by recognizing pharmacists' contributions to safety standards, quality improvement initiatives, and certification programs.

FLASCO Fall Session - Florida Society of Clinical Oncology Fall Session

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer

Pharmacist Involvement Within ASCO: Standards Development, Certification Programs, and the Potential for Pharmacy CE at Future ASCO Meetings

Trending on Pharmacy Times

Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices

MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market

Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder